Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy. A team of researchers from Colombia Engineering and Irving Institute for Cancer ...

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

Acute myeloid leukemia (AML) is a type of blood cancer ... otherwise form the key component of the body's immunodefense system, white blood cells. In a new study published in Blood Advances ...

In a paper published today in Science Immunology, the team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML).

Subscribe for FREE For patients with AML, a stem cell transplant holds the potential for a cure. The goal of the transplant is to replace the patient’s hematopoietic stem cells – cells that rejuvenate ...

Moreover, a part of AML-DC might exert tolerogenic effects on the immune system. Further investigation on this immunotherapeutical approach is necessary to define the best antigen format for this ...

For patients with AML, a stem cell transplant holds the potential for a cure. The goal of the transplant is to replace the patient’s hematopoietic stem cells – cells that rejuvenate supplies of blood ...